With a $3.7 million federal grant, MU is taking the first step in an effort to produce a more effective immunotherapy treatment for cancer patients.
This grant is part of the National Institutes of Health “Cancer MoonShot Initiative” whose goal is to make a decade’s worth of cancer research progress within five years, according to the NIH website.
The National Institutes of Health awarded the grant to University of Missouri School of Medicine Associate Professor Dr. Diana Gil Pagés.
According to an MU Public Health Relations release, Gil Pagés is using the grant to further research on immunotherapy and its effectiveness by teaching the immune system to recognize and attack cancer cells.
To read more, visit our partners at the Columbia Missourian.
